The Asian Cancer Research Group (ACRG), an independent, not-for-profit company in collaboration with BGI, the world's largest genomics organization, and The University of Hong Kong (HKU), jointly announced the publication of findings from a study of recurrent mutations in hepatocellular carcinoma (HCC), one of the most deadly cancers worldwide, in the international journal Genome Research . The study provides new insights into potential therapeutic intervention strategies for this common form of liver cancer...
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment